DXR Share Price

Open 8.70 Change Price %
High 8.70 1 Day -0.20 -2.25
Low 8.70 1 Week 0.06 0.69
Close 8.70 1 Month 0.21 2.47
Volume 1025 1 Year 0.58 7.14
52 Week High 9.80
52 Week Low 0.00
DXR Important Levels
Resistance 2 8.70
Resistance 1 8.70
Pivot 8.70
Support 1 8.70
Support 2 8.70
AMEX USA Most Active Stocks
NAK 1.39 -16.27%
NAK 1.39 -16.27%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
RBY 0.03 -70.00%
NGD 3.04 -2.56%
NGD 3.04 -2.56%
PBTH 8.23 0.37%
CVM 0.09 -10.00%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
EVK 2.60 29.35%
EVK 2.60 29.35%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
RTK 1.15 -20.14%
RTK 1.15 -20.14%
SNT 0.12 -20.00%
More..

Daxor Corporation (AMEX: DXR)

DXR Technical Analysis 3
As on 22nd Feb 2017 DXR Share Price closed @ 8.70 and we RECOMMEND Buy for LONG-TERM with Stoploss of 8.13 & Buy for SHORT-TERM with Stoploss of 8.44 we also expect STOCK to react on Following IMPORTANT LEVELS.
DXR Target for February
1st Target up-side 13.04
2nd Target up-side 16.52
3rd Target up-side 20.01
1st Target down-side 3.1
2nd Target down-side -0.38
3rd Target down-side -3.87
DXR Other Details
Segment EQ
Market Capital 33775400.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.daxor.com
DXR Address
DXR
Empire State Building
350 Fifth Avenue
New York, NY 10118
United States
Phone: 212-244-0555
Fax: 212-244-0806
DXR Latest News
The Joseph Feldschuh Buys 172000 Shares of Daxor Co. (DXR) Stock   DailyQuint   - 19th Feb 17
BRIEF-Daxor Corp says Michael Feldschuh appointed Chairman   Reuters   - 17th Feb 17
Form 8-K DAXOR CORP For: Feb 15   StreetInsider.com   - 16th Feb 17
Daxor Corp. (DXR) Mourns Loss of President/CMO Dr. Joseph Feldschuh   StreetInsider.com   - 02nd Feb 17
Hot Stocks: Aetna Inc. (NYSE:AET), Daxor Corporation (NYSE:DXR), Express, Inc ...   Benchmark Monitor   - 31st Jan 17
Recent Insider Trading: Daxor Corporation (NYSEMKT:DXR)   The Voice Registrar   - 24th Jan 17
Daxor Corporation Announces Dividend, Patent Approval, Title Change   Marketwired (press release)   - 19th Nov 16
Woman says defective semen caused autism   Cook County Record   - 25th Aug 16
Sperm bank accused of discarding hazardous materials   New York Post   - 17th Jul 15
Daxor Corporation Announces Filing of Form N-CSR for December 31, 2014   Marketwired (press release)   - 27th Feb 15
Interactive Technical Analysis Chart Daxor Corporation ( DXR AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Daxor Corporation
DXR Business Profile
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.